Takara Bio (TSE:4974) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 12, 2026)


TSE:4974 Takara Bio Inc TSE:4974
50 GF Score
Price 円1,144.00
GF Value 円860.64
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Takara Bio's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

TSE:4974 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Takara Bio's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takara Bio Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Takara Bio's Margin of Safety % (DCF Dividends Based) falls into.


TSE:4974
50GF Score
Takara Bio Inc TSE:4974
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Takara Bio (TSE:4974) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of 円1,144.00 is trading 32.9% above its estimated GF Value™ of 円860.64. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for TSE:4974:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: 円860.64 vs. price of 円1,144.00 (32.9% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the TSE:4974 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takara Bio Business Description

Other Exchanges TF2:Germany
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
50GF Score

Get the complete analysis for TSE:4974

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,144.00
Price
円860.64
GF Value